Nucleoside ribohydrolases as targets for Trichomonas vaginalis therapeutic agents. This project will evaluate two essential nucleoside ribohydrolase enzymes as targets for novel antitrichomonal drugs.
核苷核糖水解酶作为阴道毛滴虫治疗剂的靶标。
基本信息
- 批准号:9377339
- 负责人:
- 金额:$ 31.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:4-nitroimidazoleAdenosineAnionsBenign Prostatic HypertrophyBiological AssayCellsChemicalsChemistryClinicalCollectionDiversity LibraryDrug DesignDrug resistanceEnzyme InhibitionEnzyme Inhibitor DrugsEnzymesFlavonoidsGoalsGrowthGuanosineHIV-1HydrolysisImmune systemIn VitroIndividualInfectionLibrariesLigandsMalignant neoplasm of cervix uteriMalignant neoplasm of prostateMeasuresMethodsMetronidazoleMetronidazole resistanceMolecular TargetMolecular WeightNucleosidesParasitesPathway interactionsPelvic Inflammatory DiseasePharmaceutical ChemistryPharmaceutical PreparationsPredispositionProton Pump InhibitorsPurinesPyrimidineResidual stateResistanceSamplingSubstrate SpecificityTestingTherapeutic AgentsTranslatingTrichomonas InfectionsTrichomonas vaginalisUnited States National Institutes of HealthUridineValidationbasebenzimidazolecomputational chemistrycytotoxicdesigndrug discoveryenzyme activityenzyme pathwayinhibitor/antagonistnovelnovel therapeuticsnucleobasepharmacophoreresistant strainscaffoldscreeningtool
项目摘要
PROJECT SUMMARY
Trichomoniasis is the most prevalent non-viral sexually transmitted disease. Although clinical
manifestations of infection are typically mild, the immune system can be concomitantly compromised.
Individuals with trichomonal infections have a higher susceptibility to more serious conditions such as
cervical cancer, HIV-1, and pelvic inflammatory disease. More recently, trichomonal infection has also
been associated with prostate cancer and benign prostatic hyperplasia. The causative agent is the
parasitic protozoan Trichomonas vaginalis. Resistance to the existing 5-nitroimidazole class of
antitrichomonal drugs has increased markedly in recent years indicating the need for new therapies
with novel mechanisms of action. Nucleoside salvage pathway enzymes required by T. vaginalis
represent excellent targets for developing novel antitrichomonal agents. The first step in this pathway
is the hydrolysis of nucleosides to release the nucleobases. The essential enzymes
adenosine/guanosine preferring nucleoside ribohydrolase (AGNH) and uridine nucleoside ribohydrolase
(UNH) have been characterized and found to have distinct substrate specificities. Inhibitors of both
enzymes were identified using NMR-based activity assays to screen the NIH Clinical Collection. Lack
of any significant structural relationship between the two sets of inhibitors further indicates that the two
ribohydrolase enzymes are distinct, druggable targets. However, the inhibitors identified from the
limited chemistry space sampled by the NIH Clinical Collection have low ligand efficiencies and are
thus poor starting points for developing the chemical tools needed for target validation. This project will
circumvent this limitation by using a fragment-based approach to define the most critical
enzyme/inhibitor interactions. A fragment diversity library encompasses a much broader chemistry
space than is contained within the NIH Clinical Collection and will provide the optimal starting points for
developing target validation chemical tools. The specific aims of this proposal are: 1) To identify ligand-
efficient fragment inhibitors of AGNH and UNH; 2) To identify chemical tools for both AGNH and UNH
with IC50 values < 1 M; and 3) To validate AGNH and UNH as targets by demonstrating a correlation
between enzyme inhibition and antitrichomonal activity. The proposed studies will utilize established
NMR methods, computational and medicinal chemistry, and T. vaginalis growth inhibition assays. The
overall long-term goals of this project are to validate AGNH and UNH as molecular targets for novel
antitrichomonal agents, and to identify inhibitors of these enzymes that possess efficacy against both 5-
nitroimidazole-sensitive and 5-nitroimidazole-resistant strains of T. vaginalis.
项目总结
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A riboside hydrolase that salvages both nucleobases and nicotinamide in the auxotrophic parasite Trichomonas vaginalis.
- DOI:10.1016/j.jbc.2023.105077
- 发表时间:2023-09
- 期刊:
- 影响因子:4.8
- 作者:Patrone, Marco;Galasyn, Gregory S.;Kerin, Fiona;Nyitray, Mattias M.;Parkin, David W.;Stockman, Brian J.;Degano, Massimo
- 通讯作者:Degano, Massimo
NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases.
基于 NMR 的活性测定,用于确定核苷核糖水解酶的化合物抑制、IC50 值、人工活性和全细胞活性。
- DOI:10.3791/59928
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Stockman,BrianJ;Kaur,Abinash;Persaud,JuliaK;Mahmood,Maham;Thuilot,SamanthaF;Emilcar,MelissaB;Canestrari,Madison;Gonzalez,JulianaA;Auletta,Shannon;Sapojnikov,Vital;Caravan,Wagma;Muellers,SamanthaN
- 通讯作者:Muellers,SamanthaN
Parasitology assays to assess Trichomonas vaginalis nucleoside ribohydrolase inhibitors.
评估阴道毛滴虫核苷核糖水解酶抑制剂的寄生虫学测定。
- DOI:
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Chimarios,Maria;Ventura,Carlos;Stockman,BrianJ
- 通讯作者:Stockman,BrianJ
Structure-activity relationships for several series of fragment-based inhibitors that target Trichomonas vaginalis nucleoside ribohydrolase enzymes.
针对阴道毛滴虫核苷核糖水解酶的几个基于片段的抑制剂的结构-活性关系。
- DOI:
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Saljanin,Edina;Ajmal,Erum;Vanegas,Davi;VanAlstine-Parris,Melissa;Stockman,Brian
- 通讯作者:Stockman,Brian
Direct Measurement of Nucleoside Ribohydrolase Enzyme Activities in Trichomonas vaginalis Cells Using 19F and 13C-Edited 1H NMR Spectroscopy.
使用 19F 和 13C 编辑的 1H NMR 光谱直接测量阴道毛滴虫细胞中的核苷核糖水解酶活性。
- DOI:10.1021/acs.analchem.2c05330
- 发表时间:2023
- 期刊:
- 影响因子:7.4
- 作者:Stockman,BrianJ;Ventura,CarlosA;Deykina,ValerieS;KhayanLontscharitsch,Nickolas;Saljanin,Edina;Gil,Ari;Canestrari,Madison;Mahmood,Maham
- 通讯作者:Mahmood,Maham
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian J Stockman其他文献
Procedes de resonance magnetique nucleaire permettant d'identifier des sites dans une proteine e2 papillomavirus
e2 乳头瘤病毒蛋白共振磁核永久识别程序
- DOI:
- 发表时间:
2001 - 期刊:
- 影响因子:0
- 作者:
Brian J Stockman - 通讯作者:
Brian J Stockman
Brian J Stockman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
- 批准号:82074359
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
- 批准号:81570244
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
- 批准号:81171113
- 批准年份:2011
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
靶向 A2B 腺苷受体用于胰腺癌的免疫预防
- 批准号:
10929664 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Exploring the role of adenosine A2A receptors in Schizophrenia using opto-pharmacologically controlled allosteric modulation.
利用光药理学控制的变构调节探索腺苷 A2A 受体在精神分裂症中的作用。
- 批准号:
23K14685 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Role of Adenosine Kinase in Mixed Diastolic Heart Failure and Alzheimer Disease
腺苷激酶在混合性舒张性心力衰竭和阿尔茨海默病中的作用
- 批准号:
10679989 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Allostery-driven G protein selectivity in the adenosine A1 receptor
腺苷 A1 受体中变构驱动的 G 蛋白选择性
- 批准号:
BB/W016974/1 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Research Grant
Investigation of new test methods for adenosine-sensitive atrioventricular block
腺苷敏感型房室传导阻滞新检测方法的探讨
- 批准号:
23K07566 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing the role of adenosine pathway in SIV pathogenesis
探讨腺苷途径在 SIV 发病机制中的作用
- 批准号:
10760676 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
The role of A1 adenosine receptor signaling in the decline of S. pneumoniae killing by neutrophils in vaccinated aged hosts
A1 腺苷受体信号传导在疫苗接种老年宿主中中性粒细胞杀伤肺炎链球菌下降中的作用
- 批准号:
10605737 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Adenosine triphosphate as a master variable for biomass in the oceanographic context
三磷酸腺苷作为海洋学背景下生物量的主变量
- 批准号:
2319114 - 财政年份:2023
- 资助金额:
$ 31.09万 - 项目类别:
Standard Grant
Late-Stage Functionalisation of Cyclic Guanosine Monophosphate - Adenosine Monophosphate
环单磷酸鸟苷-单磷酸腺苷的后期功能化
- 批准号:
2751533 - 财政年份:2022
- 资助金额:
$ 31.09万 - 项目类别:
Studentship
Postnatal development of adenosine kinase in the brainstem network that controls breathing
控制呼吸的脑干网络中腺苷激酶的出生后发育
- 批准号:
573323-2022 - 财政年份:2022
- 资助金额:
$ 31.09万 - 项目类别:
University Undergraduate Student Research Awards














{{item.name}}会员




